Stay updated on Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants' and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The page introduces an Intervention/Treatment section header while removing the previous Intervention / Treatment header, and the site revision version updated to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-15T08:11:38.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from Revision: v3.5.4 to Revision: v3.5.5. This indicates a newer page version.
    Difference
    0.0%
    Check dated 2026-06-08T04:16:47.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Added a new publication reference about variable-dose versus continuous-dose abrocitinib in moderate-to-severe atopic dermatitis to the Publications section. This expands the study's literature context for readers.
    Difference
    0.0%
    Check dated 2026-05-24T14:53:19.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4. This reflects a minor update to the page's underlying software or documentation rather than changes to the visible study details.
    Difference
    0.0%
    Check dated 2026-05-17T10:26:35.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A new publication citation by Yosipovitch et al. is added to the Publications section, detailing a post hoc analysis of JADE COMPARE and JADE DARE related to itch relief and quality of life in atopic dermatitis. This expands the study's referenced literature and author attribution.
    Difference
    0.0%
    Check dated 2026-05-10T11:06:54.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page’s footer release/version label was updated from Revision v3.5.2 to Revision v3.5.3, indicating a minor platform update rather than a change to the trial information.
    Difference
    0.0%
    Check dated 2026-04-25T18:55:26.000Z thumbnail image

Stay in the know with updates to Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.